Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05714449 · ClinicalTrials.gov registry record · NA

OCT Eccentric Fixation and Amblyopia in Children

A NA study of Amblyopia, sponsored by State University of New York College of Optometry.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05714449 is a NA study of Amblyopia that is actively recruiting participants, run by State University of New York College of Optometry. The registered enrollment target is 30 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05714449, a NA study of Amblyopia, is actively recruiting participants, sponsored by State University of New York College of Optometry.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

Conditions Studied

Interventions

  • DEVICE eye patch
  • DEVICE After-image and MIT trainer

Study Locations (1)

New York

  • SUNY College of Optometry - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-01-25
Est. Completion 2026-01-24
Phase NA

What the Registry Record Tells You About NCT05714449

The ClinicalTrials.gov registry entry for NCT05714449 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower). The listed sponsor is State University of New York College of Optometry, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which eye patch is the first listed.

NCT05714449 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05714449 about?

NCT05714449 is a clinical study titled "OCT Eccentric Fixation and Amblyopia in Children". The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

What is the current status of trial NCT05714449?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2026-01-24.

What conditions does trial NCT05714449 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT05714449?

The interventions under investigation include: eye patch (DEVICE), After-image and MIT trainer (DEVICE).

Who is sponsoring clinical trial NCT05714449?

This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05714449 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.